# cGAS-STING Pathway-Induced BST2 Enhances HPV-Infected Keratinocyte Proliferation in Condyloma Acuminata

**Authors:** Huayu Huang, Lian Liu, Xiaohang Xie, Yuchun Cao, Zhichao Gu

PMC · DOI: 10.3390/biomedicines14020339 · Biomedicines · 2026-02-01

## TL;DR

This study shows that BST2, a gene activated by the cGAS-STING pathway, promotes the growth of HPV-infected skin cells in genital warts, suggesting it could be a new treatment target.

## Contribution

The study reveals a novel role of BST2 in HPV-induced keratinocyte proliferation through the cGAS-STING and MEK/ERK/c-Myc pathways.

## Key findings

- BST2 is significantly upregulated in CA lesions and HPV-infected keratinocytes via the cGAS/STING pathway.
- BST2 promotes keratinocyte proliferation through the MEK/ERK/c-Myc pathway.
- BST2 knockdown significantly inhibits this proliferative effect.

## Abstract

Background: Condyloma acuminata (CA) is a common sexually transmitted disease caused by human papillomavirus (HPV). Abnormal keratinocyte proliferation is a hallmark of CA, but the underlying mechanisms remain unclear. BST2, an interferon-stimulated gene, is implicated in viral inhibition and tumor cell proliferation. This study aimed to investigate whether BST2 is involved in HPV-induced keratinocyte proliferation. Methods: We conducted bioinformatics analysis using publicly available datasets from the Gene Expression Omnibus (GEO) to assess BST2 expression in CA. HPV-6/11 live virus and HPV11-E7 lentiviruses were used to infect HaCaT cells to mimic early HPV infection and viral genome integration. We examined BST2 expression in both CA patient tissue samples and in vitro models using RT-qPCR, Western blot, and immunohistochemistry. To investigate the signaling mechanisms, we used siRNA to knock down key components of the cGAS/STING pathway and examined BST2 expression levels. Additionally, we assessed keratinocyte proliferation through CCK-8 assays and cell counting. Activation of downstream signaling pathways was evaluated using Western blot analysis for key molecules in the MEK/ERK/c-Myc pathway. Results: BST2 was significantly upregulated in CA lesions and HPV-infected keratinocytes through the cGAS/STING pathway. BST2 activation promoted keratinocyte proliferation via the MEK/ERK/c-Myc pathway, and this effect was significantly inhibited by BST2 knockdown. Conclusions: HPV could promote the proliferation of keratinocytes from condyloma acuminata lesions through inducing BST2, indicating that BST2 would be a potential therapeutic target for condyloma acuminata.

## Linked entities

- **Genes:** BST2 (bone marrow stromal cell antigen 2) [NCBI Gene 684], CGAS (cyclic GMP-AMP synthase) [NCBI Gene 115004], STING1 (stimulator of interferon response cGAMP interactor 1) [NCBI Gene 340061], MAP2K7 (mitogen-activated protein kinase kinase 7) [NCBI Gene 5609], EPHB2 (EPH receptor B2) [NCBI Gene 2048], MYC (MYC proto-oncogene, bHLH transcription factor) [NCBI Gene 4609]

## Full-text entities

- **Genes:** ACTB (actin beta) [NCBI Gene 60] {aka BKRNS, BNS, BRWS1, CSMH, DDS1, PS1TP5BP1}, APC (APC regulator of Wnt signaling pathway) [NCBI Gene 324] {aka BTPS2, DESMD, DP2, DP2.5, DP3, GS}, CGAS (cyclic GMP-AMP synthase) [NCBI Gene 115004] {aka C6orf150, D4, MB21D1, h-cGAS}, AKT1 (AKT serine/threonine kinase 1) [NCBI Gene 207] {aka AKT, PKB, PKB-ALPHA, PRKBA, RAC, RAC-ALPHA}, MAP2K1 (mitogen-activated protein kinase kinase 1) [NCBI Gene 5604] {aka CFC3, MAPKK1, MEK1, MEL, MKK1, PRKMK1}, MYC (MYC proto-oncogene, bHLH transcription factor) [NCBI Gene 4609] {aka MRTL, MYCC, bHLHe39, c-Myc}, MAPK1 (mitogen-activated protein kinase 1) [NCBI Gene 5594] {aka ERK, ERK-2, ERK2, ERT1, MAPK2, NS13}, IRF3 (interferon regulatory factor 3) [NCBI Gene 3661] {aka IIAE7}, BST2 (bone marrow stromal cell antigen 2) [NCBI Gene 684] {aka CD317, HM1.24, TETHERIN}, STING1 (stimulator of interferon response cGAMP interactor 1) [NCBI Gene 340061] {aka ERIS, MITA, MPYS, NET23, SAVI, STING}, MAP2K2 (mitogen-activated protein kinase kinase 2) [NCBI Gene 5605] {aka CFC4, MAPKK2, MEK2, MKK2, PRKMK2}, IFNA1 (interferon alpha 1) [NCBI Gene 3439] {aka IFL, IFN, IFN-ALPHA, IFN-alphaD, IFNA13, IFNA@}, MAPK3 (mitogen-activated protein kinase 3) [NCBI Gene 5595] {aka ERK-1, ERK1, ERT2, HS44KDAP, HUMKER1A, P44ERK1}, POTEF (POTE ankyrin domain family member F) [NCBI Gene 728378] {aka A26C1B, POTE2alpha, POTEACTIN}, GAPDH (glyceraldehyde-3-phosphate dehydrogenase) [NCBI Gene 2597] {aka G3PD, GAPD, HEL-S-162eP}, ANXA5 (annexin A5) [NCBI Gene 308] {aka ANX5, CPB-I, ENX2, HEL-S-7, PP4, RPRGL3}, IFNE (interferon epsilon) [NCBI Gene 338376] {aka IFN-E, IFNE1, IFNT1, INFE1, PRO655}, NFKB1 (nuclear factor kappa B subunit 1) [NCBI Gene 4790] {aka CVID12, EBP-1, KBF1, NF-kB, NF-kB1, NF-kappa-B1}, MAP2K7 (mitogen-activated protein kinase kinase 7) [NCBI Gene 5609] {aka JNKK2, MAPKK7, MEK, MEK 7, MKK7, PRKMK7}, WTAP (WT1 associated protein) [NCBI Gene 9589] {aka Mum2}
- **Diseases:** sexually (MESH:D050035), cancer (MESH:D009369), infection (MESH:D007239), multiple myeloma (MESH:D009101), sexually transmitted disease (MESH:D012749), CA (MESH:D003218), breast, pancreatic, and gastric cancers (MESH:C537262), injury to (MESH:D014947), pancreatic cancer (MESH:D010190), skin diseases (MESH:D012871), Cervical cancer (MESH:D002583), CA warts (MESH:D014860), keratinocyte hyperplasia (MESH:D006965), liver cancer (MESH:D006528), HPV infection (MESH:D030361), oral, anal, and cervical warts (MESH:D002575), solid (MESH:D018250), condyloma acuminatum (MESH:D062688), oral squamous cell carcinoma (MESH:D000077195), breast cancer (MESH:D001943), gastric cancer (MESH:D013274), tumorigenesis (MESH:D063646), carcinoma cervicis uteri (MESH:C536417)
- **Chemicals:** U0126 (MESH:C113580), streptomycin (MESH:D013307), wax (MESH:D014885), CCK-8 (-), disulfide (MESH:D004220), penicillin (MESH:D010406), PI (MESH:D010716), sodium citrate (MESH:D000077559), CO2 (MESH:D002245), CCK-8 (MESH:D012844), TRIzol (MESH:C411644)
- **Species:** Mus musculus (house mouse, species) [taxon 10090], Homo sapiens (human, species) [taxon 9606], Human papillomavirus (species) [taxon 10566], Halorubrum sp. PV6 (species) [taxon 634157], human papillomavirus 11 (serotype) [taxon 10580], Human immunodeficiency virus 1 (no rank) [taxon 11676], Human papillomavirus 16 (serotype) [taxon 333760], Mycoplasma (genus) [taxon 2093]
- **Cell lines:** HPV11-E7 — Homo sapiens (Human), Telomerase immortalized cell line (CVCL_C3JB), HaCaT — Homo sapiens (Human), Spontaneously immortalized cell line (CVCL_0038), S2 — Drosophila melanogaster (Fruit fly), Spontaneously immortalized cell line (CVCL_Z232), 293FT — Homo sapiens (Human), Transformed cell line (CVCL_6911), E7 — Mus musculus (Mouse), Hybridoma (CVCL_WN41)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12938457/full.md

## Figures

5 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12938457/full.md

## References

37 references — full list in the complete paper: https://tomesphere.com/paper/PMC12938457/full.md

---
Source: https://tomesphere.com/paper/PMC12938457